 |
| Chairman Ty Danco |
Stromatec emerged from the seminal research of connective tissue expert and company founder, Dr. Helene Langevin, at the University of Vermont (UVM). Langevin’s important discoveries pertaining to tissue responses to acupuncture laid the groundwork for Stromatec’s innovative technologies. Stromatec was formed to advance these technologies and extend their applications from basic research to clinical diagnostic and treatment uses. Stromatec’s overall technology platform supports the development of diagnostic and treatment tools for researchers, physicians and allied health care providers, particularly in the area of chronic idiopathic musculoskeletal pain. Through its leading edge research and advanced technologies, Stromatec strives to create new standards of care in the diagnosis and treatment of chronic musculoskeletal pain and connective tissue abnormalities.
